Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

84.98USD
16 Feb 2018
Change (% chg)

$-0.14 (-0.16%)
Prev Close
$85.12
Open
$85.30
Day's High
$85.97
Day's Low
$84.37
Volume
382,240
Avg. Vol
468,659
52-wk High
$100.50
52-wk Low
$78.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.10 December 17 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 9 9 9 8
(2) OUTPERFORM 11 11 11 11
(3) HOLD 4 4 4 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.79 1.79 1.79 1.88

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 10 341.12 362.97 325.04 364.70
Quarter Ending Jun-18 10 359.47 370.47 342.00 385.00
Year Ending Dec-18 24 1,484.31 1,536.00 1,427.67 1,554.50
Earnings (per share)
Quarter Ending Mar-18 11 -0.10 0.10 -0.28 -0.02
Quarter Ending Jun-18 11 -0.08 0.17 -0.38 0.07
Year Ending Dec-18 20 -0.26 0.46 -1.34 -0.21

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 347.41 334.15 13.26 3.82
Quarter Ending Jun-17 308.77 317.45 8.67 2.81
Quarter Ending Mar-17 288.93 303.74 14.81 5.13
Quarter Ending Dec-16 295.96 300.09 4.13 1.40
Quarter Ending Sep-16 289.44 279.90 9.55 3.30
Earnings (per share)
Quarter Ending Sep-17 -0.14 -0.07 0.07 -48.57
Quarter Ending Jun-17 -0.21 -0.21 0.00 -0.62
Quarter Ending Mar-17 -0.29 -0.09 0.20 -68.45
Quarter Ending Dec-16 -0.38 -0.53 0.15 -39.25
Quarter Ending Sep-16 -0.39 -0.26 0.13 -32.57

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 341.12 341.12 342.46 341.72 364.70
Quarter Ending Jun-18 359.47 359.47 361.41 360.68 385.00
Year Ending Dec-18 1,484.31 1,484.31 1,489.41 1,488.31 1,554.50
Earnings (per share)
Quarter Ending Mar-18 -0.10 -0.14 -0.18 -0.18 -0.02
Quarter Ending Jun-18 -0.08 -0.07 -0.06 -0.06 0.07
Year Ending Dec-18 -0.26 -0.26 -0.23 -0.23 -0.21

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 3
Earnings
Quarter Ending Mar-18 1 0 1 1
Quarter Ending Jun-18 0 1 0 2
Year Ending Dec-18 0 0 0 3